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Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage [1]. Newborns have all the necessary anatomical, 
physiological and chemical systems to perceive pain [2]. The 
neurological system needed for this perception has already 
been formed between the 24th and 28th weeks of pregnancy [3]. 
Newborns are even more sensitive to pain than adults. Their 
suppressive mechanisms are immature which lowers the 
threshold of pain perception [4]. Treating pain in the newborn 
is essential; first, for ethical reasons and, second, because pain 
can lead to decreased oxygenation, hemodynamic instability, or 
increased intracranial pressure [5]. Moreover, painful experience 
very early in life can promote somatization later in life [6]. Many 
newborn babies undergo painful procedures such as heel pricks, 
venepuncture, and intramuscular injections.
International clinical guidelines recommend oral sucrose 
to be given to relieve procedural pain in neonate [7]. These 
recommendations are based on results from several randomized 
controlled clinical trials that conclude that sucrose is effective 
in reducing pain in preterm and term neonates [8]. Vaccination 
is the most common procedure performed in infancy, although 
new parents might have significant concerns regarding the pain 
associated with routine vaccination and may disturb mother-infant 
bonding [9]. There are limited studies where sucrose was used 
beyond neonatal age [10]. The aim and objective of this study was 
to assess analgesic effect of 24% sucrose beyond neonatal age 
up to 4 months of age by comparing its analgesic effect during 
2nd and 3rd diphtheria-pertussis-tetanus (DPT) vaccinations with 
1st DPT in healthy infants.
MATERIALS AND METHODS
This prospective study was carried out in the immunization clinic 
of the Department of Pediatrics Dr. D.Y. Patil Medical College, 
Kolhapur, Maharashtra. Written informed consent was obtained 
from the parents, and ethical clearance was taken from the 
Ethical Committee of College. Healthy term infants less than four 
months of postnatal age who were on exclusive breastfeed, and 
attended the immunization clinic for first, second, and third DPT 
vaccinations were included in the study. The following babies 
were excluded: Preterm deliveries (<37 week of gestation), 
intrauterine growth retardation, birth asphyxia (Apgar score <5), 
infants who had required hospital admission for more than 48 h, 
developmental delay with neurological deficit. The babies were 
divided into three predefined groups comprising 50 infants each 
receiving 1st DPT, 2nd DPT, and 3rd DPT.
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The name, age, sex, weight, length, and head circumference 
of babies were recorded. Oral sucrose (arbineo 24% w/v oral 
solution by Raptakos, Brett and co. Ltd.) 2 ml was given orally 
by a sterile syringe 2 min before intramuscular vaccination. 
Whole DPT vaccine, 0.5 ml by a 2 ml disposable syringe with 
23 G” needle was given on the anterolateral aspects thigh 
(left/right) after cleaning the skin with spirit, in the mother’s 
lap by single nursing staff, so that depth of needle insertion 
and duration should remain apparently same in all babies. All 
events were recorded by audio video camera (Sony camcorder 
DCR SX 63) by the investigator for total duration of 3 min 
from the insertion of needle. A different investigator analyzed 
the outcome variables from the audio-video recordings in all 
babies.
The outcome variables were total duration of cry, first cry, 
change in heart rate from baseline and modified facial coding 
score (MFCS). Crying time was defined as the number of seconds 
the baby had distressed vocalization after needle insertion within 
the first 3 min. Duration of first cry was defined as duration 
of continuous crying before a quiet interval of 5 s. The MFCS 
was calculated immediately and after 1 and 3 min of needle 
insertion. This was a composite score obtained from the sum of 
the following: Brow bulge, eye squeeze, nasolabial furrow, open 
mouth, chin quiver, and trunk movement [11]. Each parameter 
was scored “0” if absent and “1” if present and the total score 
was obtained. Heart rate in beats/min were counted just before 
and after vaccination at 3 min by a single investigator to avoid 
interpersonal error.
Every effort was made to ensure that the infant was awake 
before vaccination. The mothers were allowed to hold, talk 
or rock the baby during procedure in all groups. Non-nutritive 
sucking was not done during the procedure. All tests were 
performed between 10 am and 1 pm to avoid diurnal variation 
in pain response. All babies had been fed within 3 h before the 
interventions but had not received a feed in the previous 30 min. 
All data were analyzed by analysis of variance test for multiple 
comparisons except MFCS which was analyzed using Kruskal-
Wallis test in which p<0.05 was significant.
RESULTS
A total of 150 babies were divided into 3 predefined groups of 
50 babies each. The postnatal age, weight, sex, and time since last 
breastfeed was comparable in all three groups (Table 1). Mean total 
duration of cry was significantly longer in 3rd DPT group babies 
94.4 (30.12) s and 2nd DPT babies 50.6 (26.14) s as compared 
to 1st DPT babies 36.3 (25.34) s. The mean duration of the first 
cry was significantly higher in 3rd DPT babies 52.1 (13.12) s and 
2nd DPT babies 37.3 (15.14) s than 1st DPT babies 18.2 (14.12) s 
(Table 2).
Mean change, that is, rise in heart rate (beats/min) from 
baseline was significantly higher in 3rd DPT babies 16.6 (4.9) and 
2nd DPT babies 10.3 (5.2) as compared to 1st DPT babies 3 (2.3) 
(Table 3). Change in median MFCS was significantly higher with 
3rd DPT (3, 2) and 2nd DPT (2, 1) groups as compared to 1st DPT 
(1, 0) group at 1 and 3 min post-vaccination respectively (Fig. 1). 
Longer mean total and first cry, rise in heart rate and higher MFCS 
was maximum in 3rd DPT group.
DISCUSSION
Currently, the standard practice during routine vaccination is not 
to administer any analgesia. Sucrose as analgesic was first studied 
almost 20 years back. Even though previous neonatal studies 
demonstrated the effectiveness of sucrose, it was not used during 
routine vaccination. We hope that this study will inspire practice 
change in this area.
Unexpectedly our study demonstrated 24% sucrose had less 
analgesic activity in 3rd and 2nd DPT babies compared to 1st DPT 
babies suggested 24% sucrose had less analgesic effect between 
2 and 4 months of age babies. Two meta-analysis of 10 and 
14 randomized clinical trials on infant pain by Shah et al. [12] 
and Harrison et al. [13] found sucrose was effective in pain 
management strategy for infants and children up to 12 months 
of age. Lewindon et al. [14] found that 2 ml of 25% sucrose 
was effective during vaccination up to 6 months of age. Dilli 
et al. [15] explored pain relieving qualities of sucrose in children 
Table 1: Baseline demographic characteristics of the study subject
Parameter 1st DPT vaccination (n=50) 2nd DPT vaccination (n=50) 3rd DPT vaccination (n=50)
Age (weeks) 6.2 (2.4) 10.1 (2.3) 14.2 (2.2)
Weight (kg) 4.1 (0.4) 5.0 (0.4) 6.1 (0.3)
Time since last fed (m/n) 44 (8.4) 43 (8.3) 45 (8.2)
Mean (SD). DPT:Diphtheria-pertussis-tetanus, SD: Standard deviation
Table 2: Duration of cry in each minute, total duration of cry and duration of first cry in seconds in study groups after DPT vaccination
Duration of cry in seconds 1st DPT vaccination 2nd DPT vaccination 3rd DPT vaccination F-statistics df p-value
1st min 26.3 (12.94) 30.4 (10.34) 52.2 (8.25) 84.9 149 0.000
2nd min 8.8 (11.68) 16.2 (11.68) 30.6 (14.20) 38.85 149 0.000
3rd min 1.3 (3.34) 7.2 (4.2) 10.4 (3.22) 81.62 149 0.000
Total duration of cry 36.3 (25.34) 50.6 (26.14) 94.4 (30.12) 61.57 149 0.000
First cry 18.2 (14.12) 37.3 (15.14) 52.1 (13.12) 72.12 149 0.000
Mean(SD), DPT:Diphtheria-pertussis-tetanus, SD:Standard deviation, DF:Degrees of freedom
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up to 48 months of age and found effectiveness compared to no 
treatment. Mowery [16] did not find similar analgesia for three 
vaccinations. Barr et al. [17] reported a lack of effectiveness of 
sucrose at younger ages. Effect of sucrose was short lasting for 
more invasive procedures, especially in infants beyond newborn 
period [18]. Rogers et al. [19] found 2 ml of 24% of sucrose was 
not effective for possibly more painful procedures like bladder 
catheterization.
Evaluation of pain in neonates is difficult due to subjective 
nature of pain. Various behavioral, physiological and biological 
responses present in neonates can be used to assess pain [20]. 
Validated scores for the assessment of pain include PIPP 
(premature infant pain profile), CRIES (crying, the requirement 
of oxygen for saturation above 95%, increased vital signs, 
expression and sleeplessness), N-PASS (neonatal pain, agitation 
and sedation scale), MFCS and FLACC (face, leg, activity, cry 
and consolability pain scale). In this study, we used four easily 
detectable parameters namely first cry, total duration of cry, heart 
rate, and MFCS. Our choices of outcome measures were a result 
of a review of the literature. Without direct verbal corroboration 
from the infants, we cannot be entirely sure that any of the above 
outcome measures actually reflect the degree of pain. Slater R 
et al. [21] used electroencephalography for specific nociceptive 
brain activity and electromyography for spinal nociceptive 
reflexes for direct assessment of pain in neonate. Limitation of 
this study was that we had used MFCS pain score beyond neonatal 
age. We had not found any adverse effects of 24% sucrose in the 
present study.
The mechanism for analgesic effect of sucrose in newborn 
occurs by activation of central endogenous opioid system an action 
similar to that of opioid analgesic. Endorphins act by binding to 
opioid receptors in the central nervous system to inhibit the feeling 
of pain [17]. Sucrose solution puts two mechanisms into action: 
First, a tactile stimulation of fluid in the mouth provides an initial 
effect and, second, the sense of taste stimulation prolongs the 
effect through the release of those endogenous opiates, termed as 
“sweetness effect” [22,23]. Sucrose also reduces the response of 
sensory systems to noxious stimuli called as antinociception [24].
The reasons for less analgesic effect of 24% sucrose during 
3rd and 2nd DPT vaccinations as compared to 1st DPT in our study 
could be, first, we might had used lower concentration and lower 
dose of sucrose. According to Harrison et al. [13], and Ramenghi 
et al. [25], higher concentrations of sucrose solution might be 
more effective as the infant ages. There was insufficient evidence 
to recommend optimum dosing and age parameters for sucrose 
administration [8]. However, Lefrak et al. [26], in a review, 
highlighted that it was the sweet taste that produced the analgesic 
effect and not the volume of sucrose administered. Second, Sucrose 
might be more effective at calming infants during the recovery 
period after a painful procedure than during the actual procedure 
when pain is at its peak [17]. Third, repetitive procedural pain 
and advancing age could lead to changes in the pain sensitivity 
threshold because of rapid progressive neurological development. 
Other pharmacological measures were rarely used during 
vaccinations because of concerns about their effectiveness and 
potential adverse effects. Therefore, the effect of sucrose can be 
further enhanced by utilizing other nonpharmacological measures 
such as breastfeeding, swaddling or cuddling, skin to skin contact, 
and non-nutritive sucking.
CONCLUSION
Nearly 24% sucrose had less analgesic activity in 3rd and 2nd DPT 
babies compared to 1st DPT babies suggested 24% sucrose had 
less analgesic effect between 2 and 4 months of age babies. The 
analgesic effect of sucrose decreases as age advances.
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